Video.
Biosimilars: a cheaper and efficient alternative to name-brand drugs
Copy/paste the link below:
Copy/paste the article video embed link below:
Updated:
In partnership withThe European Commission
The European Commission's pharmaceutical reform would improve access to cheaper biosimilar medicines and speed up the time it takes to access the market.